openPR Logo
Press release

Poultry Vaccines Market Expected to Exceed USD 8.1 Billion by 2031 as Biosecurity, Sustainability, and Recombinant Technologies Influence Global Immunization Programs

Poultry Vaccines Market Expected to Exceed USD 8.1 Billion

[Atlanta, GA - May 26, 2025] - According to Clearview Market Insights, the global poultry vaccines market, valued at USD 4.6 billion in 2024, is expected to grow at a CAGR of 8.1%, reaching USD 8.1 billion by 2031. As poultry becomes the most consumed meat globally, vaccination is increasingly essential for both productivity and public health assurance.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-poultry-vaccines-market/

2024 Industry Milestones:
Hatchery Vaccine Automation Expands in Asia and LATAM
• Ceva is installing over 150 automated in ovo and spray stations in India, Brazil, and Vietnam.

mRNA Vaccines Enter Pilot Trials
• U.S. and EU veterinary companies initiate trials for rapid-response avian influenza mRNA vaccine platforms

Multivalent Combo Vaccines Reduce Labor Costs
• Zoetis introduces Poulvac® Combo ND + IBD + IB in single dose format

Executive Insights:
"Vaccination is no longer an option-it's a prerequisite for scale, trust, and resilience in poultry systems," said Dr. Mikkel Johansson, Global Poultry Vaccine Lead, Clearview Market Insights.

"Recombinant vaccines, delivered in ovo or via spray, are now frontline tools in the fight against zoonoses and productivity loss," added Marta Alvarez, Technical Director, MSD Animal Health.

Roadmap to 2031:
• 2025: Recombinant vaccines comprise 25% of the total poultry vaccine market.
• 2026: Blockchain-based vaccine records connected to traceability platforms in the EU and ASEAN.
• 2028: AI-based vaccine demand forecasting and inventory systems are operational in major hatcheries.
• 2030: Thermostable vaccines replace cold chain-reliant doses in 60+ countries
• 2031: mRNA vaccines commercialized for fast-mutating avian strains

For more insights, visit https://clearviewmarketinsights.com/

Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369

About Clearview Market Insights
Clearview Market Insights offers in-depth research on poultry health, disease prevention, and vaccine innovation. Our insights support hatcheries, integrators, and pharmaceutical leaders in developing safe, productive, and sustainable poultry systems.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Poultry Vaccines Market Expected to Exceed USD 8.1 Billion by 2031 as Biosecurity, Sustainability, and Recombinant Technologies Influence Global Immunization Programs here

News-ID: 4036369 • Views:

More Releases from ClearView Market Insights

Global Phosphorus-containing Flame Retardants Market to Surpass USD 5.2 Billion by 2031 Amid Electrification and Green Building Trends
Global Phosphorus-containing Flame Retardants Market to Surpass USD 5.2 Billion …
[Hyderabad 13th, June 2025] - The global phosphorus-containing flame retardants (PCFR) market is projected to reach USD 5,220 million by 2031, growing at a CAGR of 9.0% from USD 2,830 million in 2024, according to Clearview Market Insights. The increasing adoption of PCFRs in electric vehicles (EVs), green buildings, and smart electronics underscores a major shift toward halogen-free fire safety solutions. Request Sample @ https://clearviewmarketinsights.com/report-details/global- phosphorus-containing-flame-retardants-market/ PCFRs are preferred for their ability
Phosphorus Pentasulphide Market Set to Reach USD 1.46 Billion by 2031 as Lubricants and Battery Demand Accelerate
Phosphorus Pentasulphide Market Set to Reach USD 1.46 Billion by 2031 as Lubrica …
[Hyderabad 13th, June 2025] - Clearview Market Insights projects that the global phosphorus pentasulphide (P2S5) market will reach USD 1,460 million by 2031, growing at a CAGR of 8.5% from USD 815 million in 2024. Traditionally a staple in lubricant additives and agrochemical manufacturing, P2S5 is now gaining traction in next-generation battery technologies and mining flotation processes. Request Sample @ https://clearviewmarketinsights.com/report-details/global-phosphorus-pentasulphide-market/ The majority of current demand is anchored in the
Global Phosphorene Market Forecast to Reach USD 678 Million by 2031 Amid Demand for 2D Electronics and Energy Solutions
Global Phosphorene Market Forecast to Reach USD 678 Million by 2031 Amid Demand …
[Hyderabad 13th, June 2025] - According to Clearview Market Insights, the global phosphorene market is projected to grow from USD 104 million in 2024 to USD 678 million by 2031, exhibiting a CAGR of 31.1%. Phosphorene, the monolayer allotrope of black phosphorus, is set to revolutionize a wide range of industries, from semiconductors to biomedical engineering, thanks to its unique combination of high carrier mobility, tunable direct bandgap, and anisotropic
Phosphorus Trichloride Market to Surpass USD 2.8 Billion by 2031, Driven by Agrochemical Growth and Battery Innovation
Phosphorus Trichloride Market to Surpass USD 2.8 Billion by 2031, Driven by Agro …
[Hyderabad 13th, June 2025] - The global phosphorus trichloride (PCl3) market is expected to reach USD 2,845 million by 2031, growing at a CAGR of 9.2% from its 2024 valuation of USD 1,540 million, according to Clearview Market Insights. A surge in agrochemical production, rising demand in lithium-ion battery chemistry, and stringent fire safety regulations are driving market growth. Request Sample @ https://clearviewmarketinsights.com/report-details/global-phosphorous-trichloride-market/ PCl3 remains a crucial intermediate in organophosphorus chemistry,

All 5 Releases


More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the